Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent 7,425,542, entitled, “Stabilizing alkylglycoside compositions and methods thereof.” The patent provides broad protection for stabilized human growth hormone (hGH) formulations.
The details can be read here.
No comments:
Post a Comment